States announce $26B proposed settlement with opioid maker/distributors
State attorneys general yesterday a $26 billion proposed settlement with Johnson & Johnson and distributors McKesson, Cardinal Health and Amerisource Bergen over the companies’ alleged role in creating and fueling the opioid epidemic. A number of states have signed the agreement, which still must be signed by other state and local governments involved in the litigation. They said most of the settlement would go to opioid treatment and prevention, with each state’s share based on a formula that takes into account factors such as the number of overdose deaths, opioids prescribed and residents with substance use disorder.
Related News Articles
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…